Formulation Development

STEM CELL MARKET – Stem Cell Therapy to Redefine Regenerative Medicine

Jane C. Andrews, PhD, Frost & Sullivan Analyst, says faced with increasing challenges, such as costly treatments and treatments that are palliative rather than symptomatic, the global healthcare industry today is gradually transforming itself. With few existing therapies capable of curing or significantly changing the course of a disease, healthcare providers are starting to look toward regenerative medicine as a viable alternative.

EXCLUSIVE ONLINE CONTENT